Aura Biosciences (AURA)
(Delayed Data from NSDQ)
$6.74 USD
-0.15 (-2.18%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.76 +0.02 (0.30%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Aura Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AURA 6.74 -0.15(-2.18%)
Will AURA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AURA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AURA
Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study
AURA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for AURA
3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
Aura Energy Advances Tiris Uranium Project with DFC’s ESIA Publication
Aura Biosciences Holds 2025 Annual Stockholders Meeting
Aura Energy to Release Shares from Escrow, Boosting Market Liquidity
Aura Energy Announces Strategic Development to Boost Market Position